Abstract Body

Background

Neurological and neuropsychiatric impairments after covid-19 have been described since the beginning of the pandemic, particularly cognitive impairment, referred to as brain fog, and deficits in attention, executive function, language, processing speed, and memory are the most common symptoms. Our objective is to evaluate cognitive and neuropsychiatric impairments in patients who presented neurological manifestations associated with covid-19. 

Methods

Prospective, longitudinal, observational study designed to compare cognitive performance in patients after covid-19 over a six-month interval, also considering the presence of cognitive complaints. The study was conducted between September 2020 and February 2023 at Institute of Infectious Diseases “Emilio Ribas” and included patients aged 18 to 65 years without a history of neurological or psychiatric disorders, excluding individuals with fewer than four years of education. Analysis of inflammatory markers was performed in serum and cerebrospinal fluid (CSF). 

Results

A total of 58 patients were evaluated: 40 (69.0%) were women and 41 (70.7%) reported cognitive complaints. The mean age was 46.1 years (SD 9.8), median 45.5 years, and the mean educational level was 14.2 years (SD 3.9), median 15 years. Cognitive impairment was identified in 29 (50%) patients, with moderate or severe anxiety associated with a higher risk of cognitive impairment (OR 3.1; 95% CI 1.06–9.08; p= 0.036). We observed that the most affected domains were attention and orientation, memory, language, and visuospatial abilities. Neuropsychiatric impairment was identified in 33 (56.9%) patients, with no associated risk factors observed. Forty-four patients underwent both baseline and six-month follow-up assessments. Of these, 25 (56.8%) presented cognitive impairment at baseline, and 15 (60%) maintained the impairment after six months. In the paired analysis, despite persistently impaired test performance at both time points, there was improvement in the overall ACE-R score – in patients with ≥ 12 years of education (p= 0.024) and those with 4–11 years of education (p= 0.020) and in the ACE-R memory domain – in patients with ≥ 12 years of education (p= 0.039) and those with 4–11 years of education (p= 0.028). No significant association was found between biomarkers or proinflammatory cytokines in serum and CSF and cognitive impairment. 

Conclusions

Cognitive and neuropsychiatric impairments occur after covid-19, even in the absence of self-reported cognitive complaints.